Company Overview and News

0
Intellect Design Arena Limited - Outcome of Board Meeting

22h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

0
Intellect Design Arena Limited - Allotment of ESOP/ESPS

2018-06-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

0
Intellect Design Arena Limited - Press Release

2018-06-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

0
Intellect Design Arena Limited - Press Release

2018-06-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

7
Intellect Design Arena board approves fund raising plan

2018-06-01 thehindubusinessline
The board of Intellect Design Arena approved raising funds to the tune of ₹500 crore through issuance of securities, including equity and/or other securities convertible into equity shares, including through a qualified institutional placement. The offer could be a public issue and/or private placement and/or preferential allotment in the form of equity/warrants to promoters/others.
ICICIBANK 532174 IBN INTELLECT 538835

0
Intellect Design Arena Limited - Outcome of Board Meeting

2018-06-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

6
Fund-raising: Intellect Design, Som Distilleries

2018-05-31 thehindubusinessline
The boards of Intellect Design Arena and Som Distilleries & Breweries will meet on Friday to consider fund-raising plans. Som Distilleries will approve a further issue of equity shares to investors under the FPI/FDI route on preferential basis and issue of convertible equity warrants to promoters on preferential basis.
HDB 500180 HDFCBANK INTELLECT 538835

27
Closing Bell: Sensex ends below 35K, sheds 216 pts; Nifty Bank loses 359 pts

2018-05-29 moneycontrol
Earnings: Power Grid Corporation has reported 4.6 percent rise in its Q4FY18 net profit at Rs 2,004.7 crore against Rs 1,916.4 crore in the same quarter last fiscal.
500325 RELIANCE 532712 533278 STAR RCOM 532483 RIGD GODFRYPHLP HDFCBANK CLNDY RLNIY BANKINDIA IBN 532967 538835 KIRIINDUS DCMSRMIND 532941 532149 BHEL CNRYY 532531 ICICIBANK CORDSCABLE HDB 532174 500180 BRHTY INTELLECT 500103 534809 PCJEWELLER 500163 CANBK 523369 COALINDIA

21
Market Live: Sensex dips 200 pts amid weak rupee; MM rallies on Q4 earnings

2018-05-29 moneycontrol
Earnings Reaction: Godfrey Phillips India's March quarter profit dropped 22.8 percent year-on-year to Rs 43.1 crore and revenue from operations declined 37.6 percent to Rs 543.3 crore.
500325 RELIANCE 532955 532712 STAR RCOM RIGD GODFRYPHLP HDFCBANK RLNIY BANKINDIA IBN 538835 DCMSRMIND 532941 532149 BHEL 539207 532531 ICICIBANK CORDSCABLE HDB 532174 500180 BRHTY INTELLECT 500103 RECLTD 500163 523369 MANPASAND

23
Market Live: Sensex falls 100 pts, rupee slips 50 paise; BHEL up 9% on Q4 nos

2018-05-29 moneycontrol
Earnings: M&M's March quarter earnings beat analyst expectations as profit grew by 50 percent year-on-year to Rs 1,155 crore and revenue increased 25.6 percent to Rs 13,189 crore during the quarter.
500325 AUROPHARMA RELIANCE 532955 532712 533106 STAR RCOM OIL RIGD HDFCBANK RLNIY BANKINDIA 524804 IBN 538835 532941 532149 BHEL 539207 532531 ICICIBANK CORDSCABLE HDB 532174 500180 ARBQY BRHTY INTELLECT 500103 RECLTD MANPASAND

23
Market Live: Sensex rangebound, PSU Bank index loses 2%; BHEL up 9% on Q4 nos

2018-05-29 moneycontrol
Market Update: Benchmark indices as well as broader markets are in a consolidation mode after sharp rally seen in previous three consecutive sessions. Investors closely monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 STAR RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 538835 BHEL 539207 532531 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 BRHTY INTELLECT 500103 RECLTD MANPASAND ADFFOODS

0
Intellect Design Arena Limited - Allotment of ESOP/ESPS

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

0
Intellect Design Arena Limited - Financial Result Updates

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

0
Intellect Design Arena Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INTELLECT 538835

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

1h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to NSE:INTELLECT / Intellect Design Arena Ltd on message board site Silicon Investor.

Very GOOD news for OncoSec: NEW Intellectual Property